Literature DB >> 22430275

Effect of postdiagnosis weight change on hot flash status among early-stage breast cancer survivors.

Bette J Caan1, Jennifer A Emond, H Irene Su, Ruth E Patterson, Shirley W Flatt, Ellen B Gold, Vicky A Newman, Cheryl L Rock, Cynthia A Thomson, John P Pierce.   

Abstract

PURPOSE: Hot flashes (HF) affect a large proportion of breast cancer (BC) survivors and can negatively affect their quality of life. Treatments other than estrogen replacement to alleviate HF are needed. Body weight is related to hot flashes, but little is known about the effect of weight change on HF. PATIENTS AND METHODS: We used data from 3,088 women previously treated for early-stage BC who were enrolled onto the Women's Healthy Eating and Living study to examine the association between weight change after a breast cancer diagnosis and the odds of reporting HF.
RESULTS: Overall, 36.1% of participants reported moderate to severe HF at study entry. At 2 years postdiagnosis, 69.2% of women remained within 10%, 4.8% lost at least 10%, and 26.0% gained at least 10% of their prediagnosis weight. Those who gained at least 10% of their prediagnosis weight had a greater risk of reporting HF than women who remained weight stable in that same period (odds ratio [OR], 1.33; 95% CI, 1.11 to 1.60; P = .003). Weight loss of at least 10% of prediagnosis weight was associated with a nonsignificant reduced risk (OR, 0.72; 95% CI, 0.47 to 1.08; P = .118) of reporting HF. However, the trend of weight change (weight loss and weight gain) on HF was significant both when examined categorically (P = .03) and continuously (P < .001).
CONCLUSION: Prevention of weight gain after a BC diagnosis-a modifiable behavior-may offer a viable intervention for relief of HF. Effects of intentional weight loss in BC survivors requires further study.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22430275      PMCID: PMC4874147          DOI: 10.1200/JCO.2011.36.8597

Source DB:  PubMed          Journal:  J Clin Oncol        ISSN: 0732-183X            Impact factor:   44.544


  37 in total

1.  Lifestyle factors: are they related to vasomotor symptoms and do they modify the effectiveness or side effects of hormone therapy?

Authors:  Gail A Greendale; Ellen B Gold
Journal:  Am J Med       Date:  2005-12-19       Impact factor: 4.965

2.  Longitudinal analysis of the association between vasomotor symptoms and race/ethnicity across the menopausal transition: study of women's health across the nation.

Authors:  Ellen B Gold; Alicia Colvin; Nancy Avis; Joyce Bromberger; Gail A Greendale; Lynda Powell; Barbara Sternfeld; Karen Matthews
Journal:  Am J Public Health       Date:  2006-05-30       Impact factor: 9.308

3.  Short version of the CES-D (Burnam screen) for depression in reference to the structured psychiatric interview.

Authors:  A Tuunainen; R D Langer; M R Klauber; D F Kripke
Journal:  Psychiatry Res       Date:  2001-09-20       Impact factor: 3.222

4.  Objective cancer-related variables are not associated with depressive symptoms in women treated for early-stage breast cancer.

Authors:  Wayne A Bardwell; Loki Natarajan; Joel E Dimsdale; Cheryl L Rock; Joanne E Mortimer; Kathy Hollenbach; John P Pierce
Journal:  J Clin Oncol       Date:  2006-05-01       Impact factor: 44.544

5.  Lifestyle and demographic factors in relation to vasomotor symptoms: baseline results from the Study of Women's Health Across the Nation.

Authors:  Ellen B Gold; Gladys Block; Sybil Crawford; Laurie Lachance; Gordon FitzGerald; Heidi Miracle; Sheryl Sherman
Journal:  Am J Epidemiol       Date:  2004-06-15       Impact factor: 4.897

6.  Sociodemographic characteristics, biological factors, and symptom reporting in midlife women.

Authors:  J Wilbur; A M Miller; A Montgomery; P Chandler
Journal:  Menopause       Date:  1998       Impact factor: 2.953

7.  Post-diagnosis weight gain and breast cancer recurrence in women with early stage breast cancer.

Authors:  Bette J Caan; Jennifer A Emond; Loki Natarajan; Adrienne Castillo; Erica P Gunderson; Laurel Habel; Lovell Jones; Vicky A Newman; Cheryl L Rock; Martha L Slattery; Marcia L Stefanick; Barbara Sternfeld; Cynthia A Thomson; John P Pierce
Journal:  Breast Cancer Res Treat       Date:  2006-03-16       Impact factor: 4.872

Review 8.  Tamoxifen pharmacogenomics: the role of CYP2D6 as a predictor of drug response.

Authors:  M P Goetz; A Kamal; M M Ames
Journal:  Clin Pharmacol Ther       Date:  2007-09-19       Impact factor: 6.875

9.  Measuring hot flashes: summary of a National Institutes of Health workshop.

Authors:  Heather G Miller; Rose Maria Li
Journal:  Mayo Clin Proc       Date:  2004-06       Impact factor: 7.616

10.  Pre-diagnosis body mass index, post-diagnosis weight change, and prognosis among women with early stage breast cancer.

Authors:  Bette J Caan; Marilyn L Kwan; Georgina Hartzell; Adrienne Castillo; Martha L Slattery; Barbara Sternfeld; Erin Weltzien
Journal:  Cancer Causes Control       Date:  2008-08-28       Impact factor: 2.506

View more
  13 in total

1.  Associations between self-reported post-diagnosis physical activity changes, body weight changes, and psychosocial well-being in breast cancer survivors.

Authors:  Siobhan M Phillips; Edward McAuley
Journal:  Support Care Cancer       Date:  2014-07-15       Impact factor: 3.603

2.  Bee pollen and honey for the alleviation of hot flushes and other menopausal symptoms in breast cancer patients.

Authors:  Karsten Münstedt; Benjamin Voss; Uwe Kullmer; Ursula Schneider; Jutta Hübner
Journal:  Mol Clin Oncol       Date:  2015-05-04

3.  Management of Potential Long-Term Toxicities in Breast Cancer Patients.

Authors:  C C O'Sullivan; K J Ruddy
Journal:  Curr Breast Cancer Rep       Date:  2016-10-13

4.  Survivorship: nutrition and weight management, Version 2.2014. Clinical practice guidelines in oncology.

Authors:  Crystal S Denlinger; Jennifer A Ligibel; Madhuri Are; K Scott Baker; Wendy Demark-Wahnefried; Don Dizon; Debra L Friedman; Mindy Goldman; Lee Jones; Allison King; Grace H Ku; Elizabeth Kvale; Terry S Langbaum; Kristin Leonardi-Warren; Mary S McCabe; Michelle Melisko; Jose G Montoya; Kathi Mooney; Mary Ann Morgan; Javid J Moslehi; Tracey O'Connor; Linda Overholser; Electra D Paskett; Jeffrey Peppercorn; Muhammad Raza; M Alma Rodriguez; Karen L Syrjala; Susan G Urba; Mark T Wakabayashi; Phyllis Zee; Nicole R McMillian; Deborah A Freedman-Cass
Journal:  J Natl Compr Canc Netw       Date:  2014-10       Impact factor: 11.908

5.  Survivorship, Version 2.2017, NCCN Clinical Practice Guidelines in Oncology.

Authors:  Crystal S Denlinger; Tara Sanft; K Scott Baker; Shrujal Baxi; Gregory Broderick; Wendy Demark-Wahnefried; Debra L Friedman; Mindy Goldman; Melissa Hudson; Nazanin Khakpour; Allison King; Divya Koura; Elizabeth Kvale; Robin M Lally; Terry S Langbaum; Michelle Melisko; Jose G Montoya; Kathi Mooney; Javid J Moslehi; Tracey O'Connor; Linda Overholser; Electra D Paskett; Jeffrey Peppercorn; M Alma Rodriguez; Kathryn J Ruddy; Paula Silverman; Sophia Smith; Karen L Syrjala; Amye Tevaarwerk; Susan G Urba; Mark T Wakabayashi; Phyllis Zee; Deborah A Freedman-Cass; Nicole R McMillian
Journal:  J Natl Compr Canc Netw       Date:  2017-09       Impact factor: 11.908

6.  Weight, inflammation, cancer-related symptoms and health related quality of life among breast cancer survivors.

Authors:  Ikuyo Imayama; Catherine M Alfano; Marian L Neuhouser; Stephanie M George; Ashley Wilder Smith; Richard N Baumgartner; Kathy B Baumgartner; Leslie Bernstein; Ching-Yun Wang; Catherine Duggan; Rachel Ballard-Barbash; Anne McTiernan
Journal:  Breast Cancer Res Treat       Date:  2013-07       Impact factor: 4.872

7.  Efficacy of a web-based women's health survivorship care plan for young breast cancer survivors: a randomized controlled trial.

Authors:  H Irene Su; Shaylyn Stark; Brian Kwan; Sarah Boles; Diana Chingos; Jennifer Ehren; Jessica R Gorman; Michael Krychman; Sally A D Romero; Jun J Mao; John P Pierce; Loki Natarajan
Journal:  Breast Cancer Res Treat       Date:  2019-05-03       Impact factor: 4.872

8.  Impact of a behavioral weight loss intervention on comorbidities in overweight and obese breast cancer survivors.

Authors:  Rebecca L Sedjo; Shirley W Flatt; Tim Byers; Graham A Colditz; Wendy Demark-Wahnefried; Patricia A Ganz; Kathleen Y Wolin; Anthony Elias; Helen Krontiras; Jingxia Liu; Michael Naughton; Bilgé Pakiz; Barbara A Parker; Holly Wyatt; Cheryl L Rock
Journal:  Support Care Cancer       Date:  2016-03-05       Impact factor: 3.603

9.  Weight gain prior to entry into a weight-loss intervention study among overweight and obese breast cancer survivors.

Authors:  Rebecca L Sedjo; Tim Byers; Patricia A Ganz; Graham A Colditz; Wendy Demark-Wahnefried; Kathleen Y Wolin; Maria Azrad; Cheryl L Rock
Journal:  J Cancer Surviv       Date:  2014-03-06       Impact factor: 4.442

10.  Body weight changes in breast cancer patients following adjuvant chemotherapy and contributing factors.

Authors:  Jian-Sheng Wang; Hui Cai; Chang-Yan Wang; Jia Zhang; Ming-Xin Zhang
Journal:  Mol Clin Oncol       Date:  2013-10-30
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.